Search by Drug Name or NDC
NDC 73581-0204-02 NASAL DECONGESTANT PE 25 mg/1 Details
NASAL DECONGESTANT PE 25 mg/1
NASAL DECONGESTANT PE is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by YYBA CORP. The primary component is PHENYLEPHRINE HYDROCHLORIDE.
Product Information
| NDC | 73581-0204 |
|---|---|
| Product ID | 73581-204_0e13a1f1-87bb-b26e-e063-6294a90a87f8 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | NASAL DECONGESTANT PE |
| Proprietary Name Suffix | 10mg |
| Non-Proprietary Name | PHENYLPHRINE HCL |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1 |
| Substance Name | PHENYLEPHRINE HYDROCHLORIDE |
| Labeler Name | YYBA CORP |
| Pharmaceutical Class | Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M012 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 73581-0204-02 (73581020402)
| NDC Package Code | 73581-204-02 |
|---|---|
| Billing NDC | 73581020402 |
| Package | 200 TABLET in 1 BOTTLE (73581-204-02) |
| Marketing Start Date | 2021-08-03 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |